Haemonetics Corporation (HAE) — Cash Flow-to-Debt Ratio
Haemonetics Corporation (HAE) has a Cash Flow-to-Debt Ratio of 0.04x as of March 2026, meaning its operating cash flow of $70.94 Million could theoretically repay 0% of its total liabilities ($1.60 Billion) in one year. See how much free cash does Haemonetics Corporation generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Haemonetics Corporation Cash Flow-to-Debt Ratio (1992–2026)
Historical debt coverage capacity for Haemonetics Corporation across 35 annual periods. Also explore Haemonetics Corporation (HAE) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Haemonetics Corporation (1992–2026)
Year-by-year debt coverage analysis for Haemonetics Corporation. For market capitalisation and broader financial context, see Haemonetics Corporation market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.20x | $293.22 Million | $1.50 Billion | ▲ +75.1% |
| 2025 | 0.11x | $181.72 Million | $1.63 Billion | ▼ -24.2% |
| 2024 | 0.15x | $181.75 Million | $1.24 Billion | ▼ -39.8% |
| 2023 | 0.24x | $273.06 Million | $1.12 Billion | ▲ +57.6% |
| 2022 | 0.16x | $172.26 Million | $1.11 Billion | ▲ +55.2% |
| 2021 | 0.10x | $108.81 Million | $1.09 Billion | ▼ -57.0% |
| 2020 | 0.23x | $158.22 Million | $680.00 Million | ▼ -11.3% |
| 2019 | 0.26x | $159.28 Million | $606.90 Million | ▼ -42.2% |
| 2018 | 0.45x | $220.35 Million | $484.91 Million | ▲ +42.0% |
| 2017 | 0.32x | $159.74 Million | $499.10 Million | ▲ +56.8% |
| 2016 | 0.20x | $121.86 Million | $597.13 Million | ▲ +5.4% |
| 2015 | 0.19x | $127.18 Million | $657.00 Million | ▼ -5.5% |
| 2014 | 0.20x | $139.52 Million | $681.23 Million | ▲ +66.8% |
| 2013 | 0.12x | $85.07 Million | $692.69 Million | ▼ -81.3% |
| 2012 | 0.66x | $115.32 Million | $175.56 Million | ▼ -21.7% |
| 2011 | 0.84x | $123.45 Million | $147.13 Million | ▲ +3.4% |
| 2010 | 0.81x | $130.67 Million | $161.02 Million | ▼ -23.4% |
| 2009 | 1.06x | $116.36 Million | $109.81 Million | ▲ +56.6% |
| 2008 | 0.68x | $77.67 Million | $114.76 Million | ▼ -24.6% |
| 2007 | 0.90x | $83.56 Million | $93.09 Million | ▲ +10.0% |
| 2006 | 0.82x | $85.62 Million | $104.89 Million | ▲ +29.1% |
| 2005 | 0.63x | $71.21 Million | $112.62 Million | ▲ +8.2% |
| 2004 | 0.58x | $74.61 Million | $127.64 Million | ▲ +82.0% |
| 2003 | 0.32x | $43.67 Million | $135.97 Million | ▲ +27.6% |
| 2002 | 0.25x | $32.24 Million | $128.10 Million | ▼ -46.5% |
| 2001 | 0.47x | $61.01 Million | $129.80 Million | ▲ +25.4% |
| 2000 | 0.37x | $53.47 Million | $142.67 Million | ▲ +49.6% |
| 1999 | 0.25x | $33.70 Million | $134.50 Million | ▲ +74.4% |
| 1998 | 0.14x | $20.40 Million | $142.00 Million | ▼ -47.2% |
| 1997 | 0.27x | $26.70 Million | $98.20 Million | ▼ -64.9% |
| 1996 | 0.77x | $54.80 Million | $70.80 Million | ▲ +333.1% |
| 1995 | 0.18x | $15.60 Million | $87.30 Million | ▼ -53.7% |
| 1994 | 0.39x | $27.00 Million | $69.90 Million | ▼ -42.3% |
| 1993 | 0.67x | $35.90 Million | $53.60 Million | ▲ +93.1% |
| 1992 | 0.35x | $18.80 Million | $54.20 Million | — |